Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06425991
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-05-17
Brief Title:
A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Relapsed or Refractory Multiple Myeloma |
Keywords:
| Name | View |
|---|---|
| 1-3 prior lines | View |